G43.119 Insurance Policy Changes

ICD-10 G43.119 is officially defined as "Migraine with aura, intractable, without status migrainosus." code G43.119 is referenced in 5 tracked payer policy changes from Independence Blue Cross and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code G43.119 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Independence Blue Cross · Effective Jan 1, 2026Medium impact
MA05.071, Remote Electrical Neuromodulation for Migraines
Independence Blue Cross reissued MA05.071 with no substantive changes to Remote Electrical Neuromodulation (REN/Nerivio) coverage for migraine prevention. The policy establishes medical necessity criteria for adults (18+) and pediatric patients (8-17) with 6-24 headache days per 28-day period, requiring either failed preventive medications, pregnancy/breastfeeding status, medication overuse headache risk, or drug-drug interaction concerns. Acute migraine treatment remains non-covered (experimental/investigational). Billing teams must ensure claims comply with these eligibility criteria and HCPCS code A4540 is used for device billing.
Independence Blue Cross · Effective Jan 1, 2026Medium impact
05.00.86, Remote Electrical Neuromodulation for Migraines
Independence Blue Cross has upgraded Remote Electrical Neuromodulation (REN) devices like Nerivio from Experimental/Investigational to Medically Necessary for migraine prevention in adults (18+) and pediatric patients (8-17) who meet specific clinical criteria, including migraine frequency of 6-24 headache days per 28-day period and failure of or contraindication to preventive medications. This policy is effective January 1, 2026, and represents a significant coverage expansion that will allow claims for previously denied devices.
Aetna · Identified Aug 15, 2026Medium impact
Headaches: Nonsurgical Management (CPB 0462, reviewed 2026-07-23)
Aetna covers intravenous dihydroergotamine (DHE) for status migrainosus, for other intractable severe migraine attacks unresponsive to analgesics and triptans, and for cluster headache attacks that do not respond to oxygen or triptans, when given in the emergency room, hospital or urgent care setting, and covers it for medication overuse headache in the inpatient setting. Aetna also covers intramuscular ketorolac for short-term management of acute migraine (5 days or less), intramuscular and intravenous steroids and intravenous magnesium for acute migraines, caffeine citrate infusion for post lumbar puncture headache when the member is unable to take caffeine orally, and eptinezumab-jjmr (Vyepti) for preventive migraine treatment in an adult when the criteria are met. Aetna considers cranio-sacral therapy, intra-oral splints for tension-type headaches, IV DHE for other headache types, and a list of other nonsurgical migraine and cluster headache interventions experimental, investigational or unproven.
Independence Blue Cross · Effective Jan 1, 2026Low impact
MA05.071, Remote Electrical Neuromodulation for Migraines
Independence Blue Cross reissued MA05.071 with no substantive changes to remote electrical neuromodulation (REN/Nerivio) coverage for migraine prevention. The policy maintains existing coverage criteria for adults (18+) and pediatric patients (8-17) who meet specific headache frequency and medication response thresholds, and continues to exclude acute migraine treatment as experimental/investigational. This is an annual review reissuance effective 01/01/2026 with no billing workflow changes required.
Independence Blue Cross · Effective Jan 1, 2026Low impact
05.00.86, Remote Electrical Neuromodulation for Migraines
Independence Blue Cross has reissued policy 05.00.86 with NO CHANGES to the existing coverage criteria for remote electrical neuromodulation (REN) devices like Nerivio for migraine prevention. The policy status remains MEDICALLY NECESSARY for qualifying adults (18+) and pediatric patients (8-17) who meet specific clinical criteria. This is an administrative reissuance for annual review purposes with an effective date of January 1, 2026.

Watch G43.119

Get one email when a payer policy names G43.119, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code G43.119?

There are 5 tracked policy changes affecting code G43.119, including updates from Independence Blue Cross, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code G43.119?

Payers that have issued tracked updates for code G43.119 include: Independence Blue Cross, Aetna.

How do I get notified when code G43.119 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code G43.119. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code G43.119?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

MA05.071, Remote Electrical Neuromodulation for Migraines

05.00.86, Remote Electrical Neuromodulation for Migraines

Headaches: Nonsurgical Management (CPB 0462, reviewed 2026-07-23)